Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Zheng N, Shabek N. Ubiquitin ligases: structure, function, and regulation. Annu Rev Biochem. 2017;86:129–57.

Article  CAS  PubMed  Google Scholar 

Li Y, Zhu J, Yu Z, et al. Regulation of apoptosis by ubiquitination in liver cancer. Am J Cancer Res. 2023;13(10):4832–71.

CAS  PubMed  PubMed Central  Google Scholar 

Su Y, Meng L, Ge C, et al. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling. J Exp Clin Cancer Res. 2024;43(1):142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng Y, Zhang Y, Cai Y, et al. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Cell Death Dis. 2020;11(2):89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20(11):1242–53.

Article  CAS  PubMed  Google Scholar 

Lu K, Pan Y, Huang Z, et al. TRIM proteins in hepatocellular carcinoma. J Biomed Sci. 2022;29(1):69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morreale FE, Walden H. Types of ubiquitin ligases. Cell. 2016;165(1):248-248.e1.

Article  CAS  PubMed  Google Scholar 

Cabana VC, Lussier MP. From drosophila to human: biological function of E3 ligase godzilla and its role in disease. Cells. 2022;11(3).

Han S, Wang R, Zhang Y, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18(6):2292–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Decoding cancer metastasis. Nat Cell Biol. 2018;20(8):859.

Yang Q, Zhao J, Chen D, et al. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2(1):23.

Article  PubMed  PubMed Central  Google Scholar 

Uchida C, Kitagawa M. RING-, HECT-, and RBR-type E3 ubiquitin ligases: involvement in human cancer. Curr Cancer Drug Targets. 2016;16(2):157–74.

Article  CAS  PubMed  Google Scholar 

Ringelhan M, Pfister D, O’Connor T, et al. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222–32.

Article  CAS  PubMed  Google Scholar 

Fang S, Jensen JP, Ludwig RL, et al. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem. 2000;275(12):8945–51.

Article  CAS  PubMed  Google Scholar 

Klein AM, de Queiroz RM, Venkatesh D, et al. The roles and regulation of MDM2 and MDMX: it is not just about p53. Genes Dev. 2021;35(9–10):575–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng X, Liu X, Guo X, et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 2018;564(7734):130–5.

Article  CAS  PubMed  Google Scholar 

Hoff H, Kolar P, Ambach A, et al. CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch. Mol Immunol. 2010;47(10):1875–81.

Article  CAS  PubMed  Google Scholar 

Bhowmick P, Pancsa R, Guharoy M, et al. Functional diversity and structural disorder in the human ubiquitination pathway. PLoS ONE. 2013;8(5): e65443.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Bengtson MH, Ulbrich A, et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle’s dynamics and signaling. PLoS ONE. 2008;3(1): e1487.

Article  PubMed  PubMed Central  Google Scholar 

Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem. 2009;78:399–434.

Article  CAS  PubMed  Google Scholar 

Rotin D, Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol. 2009;10(6):398–409.

Article  CAS  PubMed  Google Scholar 

Wenzel DM, Lissounov A, Brzovic PS, et al. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature. 2011;474(7349):105–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503–33.

Article  CAS  PubMed  Google Scholar 

Pao KC, Wood NT, Knebel A, et al. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. Nature. 2018;556(7701):381–5.

Article  CAS  PubMed  Google Scholar 

Yin J, Zhu JM, Shen XZ. The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma. Int J Cancer. 2015;136(2):249–57.

Article  CAS  PubMed  Google Scholar 

Honda R, Yasuda H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene. 2000;19(11):1473–6.

Article  CAS  PubMed  Google Scholar 

Vousden KH, Lu X. Live or let die: the cell’s response to p53. Nat Rev Cancer. 2002;2(8):594–604.

Article  CAS  PubMed  Google Scholar 

Jing Z, Nan KJ, Hu ML. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. World J Gastroenterol. 2005;11(13):1910–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X. p53 regulation: teamwork between RING domains of Mdm2 and MdmX. Cell Cycle. 2011;10(24):4225–9.

Article  CAS  PubMed  Google Scholar 

Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol. 2003;13(1):49–58.

Article  CAS  PubMed  Google Scholar 

Chibaya L, Karim B, Zhang H, et al. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci USA. 2021;118(4): e2003193118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Q, He W, Liu Z, et al. LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX. Cell Death Discov. 2023;9(1):414.